Global Drug Eluting Balloon for Peripheral Artery Disease Market Growth 2026-2032
The global Drug Eluting Balloon for Peripheral Artery Disease market size is predicted to grow from US$ 793 million in 2025 to US$ 1777 million in 2032; it is expected to grow at a CAGR of 12.2% from 2026 to 2032.
Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing ?limus? exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a ?leave nothing behind? concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability?often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD?supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.
The hurdle is no longer ?can you launch,? but ?can you scale with reproducibility and compliant delivery.? As drug?device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from ?operator preference?driven? toward ?pathway management?driven? growth?where evidence communication, technique standardization, and supply reliability matter more than ever.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or ?limus? agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloon for Peripheral Artery Disease Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloon for Peripheral Artery Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloon for Peripheral Artery Disease sales for 2026 through 2032. With Drug Eluting Balloon for Peripheral Artery Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloon for Peripheral Artery Disease industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloon for Peripheral Artery Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloon for Peripheral Artery Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloon for Peripheral Artery Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloon for Peripheral Artery Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloon for Peripheral Artery Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloon for Peripheral Artery Disease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Drug-eluting/drug-coated balloons (DEB/DCB) for peripheral artery disease (PAD) are angioplasty balloons coated with an antiproliferative drug (predominantly paclitaxel, with ongoing ?limus? exploration) plus an excipient/carrier matrix. During inflation, they deliver mechanical lumen gain while rapidly transferring drug into the vessel wall to suppress neointimal hyperplasia and reduce restenosis and repeat interventions. Centered on a ?leave nothing behind? concept, PAD-focused DCBs aim to preserve future treatment flexibility while improving durability?often used in conjunction with lesion preparation (plaque modification, scoring/cutting balloons) and intravascular imaging (e.g., IVUS) to enable more refined and repeatable peripheral vascular repair.In 2025, global Drug Eluting Balloon for Peripheral Artery Disease production reached approximately 773 k units and price is 1048 USD/Unit.The average gross profit margin of this product is 73%.
PAD care continues to shift toward minimally invasive, repair-centric strategies, and DCBs address a core clinical pain point: durable patency with reduced stent burden and fewer reinterventions. Importantly, the safety boundary has become clearer. In July 2023, the U.S. FDA updated its communication stating that the totality of available evidence does not indicate an excess late mortality risk for paclitaxel-coated devices in PAD?supporting more predictable hospital governance and pathway adoption. In parallel, leading medtech companies have highlighted drug-coated balloons as a contributor to peripheral interventions momentum in annual reporting, signaling a transition from selective use toward routine toolset adoption.
The hurdle is no longer ?can you launch,? but ?can you scale with reproducibility and compliant delivery.? As drug?device combination products, DCBs are highly sensitive to coating integrity, particulate control, batch-to-batch dose consistency, and shelf-life stability?where process drift can translate into outsized clinical reputation and access risk. Meanwhile, cost-containment intensifies the need to balance quality systems, supply assurance, and manufacturing efficiency. In China, drug-coated balloons have been included in national centralized procurement with publicly announced results, accelerating a more rules-based and scale-driven competitive phase. Brokerage commentary broadly notes that procurement reforms can standardize purchasing and usage and improve market order, while near-term price pressure forces value to be rebuilt through efficiency and differentiated evidence.
Demand is consolidating around repeatable techniques and bundled solutions. High recurrence and reintervention sensitivity in PAD elevate integrated optimization?lesion preparation, drug-transfer efficiency, and durable patency?driving more routine combination of DCBs with plaque-modification tools, specialty scoring/cutting balloons, and intravascular imaging (e.g., IVUS). Under tighter compliance and procurement frameworks, hospitals increasingly formalize device bundles and clinical pathways, shifting adoption from ?operator preference?driven? toward ?pathway management?driven? growth?where evidence communication, technique standardization, and supply reliability matter more than ever.
Upstream differentiation is ultimately an integrated ?materials?coating?validation? capability rather than a simple bill of materials. Key inputs include balloon/catheter polymers and reinforcements (films, multi-durometer shafts, liners, braids/coils), drug APIs (paclitaxel or ?limus? agents) with excipient/carrier systems, coating solvents and metrology consumables, lubricious/hydrophilic surface coatings, plus sterile barrier packaging and sterilization services. As regulatory scrutiny, centralized procurement fulfillment, and global compliance advance in parallel, medical-grade traceability, robust change control, and clean manufacturing at the supplier level directly shape yield, release consistency, and long-term commercial credibility.
LP Information, Inc. (LPI) ' newest research report, the ?Drug Eluting Balloon for Peripheral Artery Disease Industry Forecast? looks at past sales and reviews total world Drug Eluting Balloon for Peripheral Artery Disease sales in 2025, providing a comprehensive analysis by region and market sector of projected Drug Eluting Balloon for Peripheral Artery Disease sales for 2026 through 2032. With Drug Eluting Balloon for Peripheral Artery Disease sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Drug Eluting Balloon for Peripheral Artery Disease industry.
This Insight Report provides a comprehensive analysis of the global Drug Eluting Balloon for Peripheral Artery Disease landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Drug Eluting Balloon for Peripheral Artery Disease portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Drug Eluting Balloon for Peripheral Artery Disease market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Drug Eluting Balloon for Peripheral Artery Disease and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Drug Eluting Balloon for Peripheral Artery Disease.
This report presents a comprehensive overview, market shares, and growth opportunities of Drug Eluting Balloon for Peripheral Artery Disease market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Iliac Artery
- Femoropopliteal
- Other
- In-Stent Restenosi
- De Novo
- Small Vessel
- Semi-/Compliant
- Non-compliant
- Other
- Hospitals
- Ambulatory Surgery Centers
- Catheterization Laboratories
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Medtronic
- Boston Scientific
- BD
- Acotec
- Philips
- Lepu Medical
- Eurocor
- MicroPort Medical
- What is the 10-year outlook for the global Drug Eluting Balloon for Peripheral Artery Disease market?
- What factors are driving Drug Eluting Balloon for Peripheral Artery Disease market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How doDrug Eluting Balloon for Peripheral Artery Disease market opportunities vary by end market size?
- How does Drug Eluting Balloon for Peripheral Artery Disease break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloon for Peripheral Artery Disease Segment by Type
2.2.1 Iliac Artery
2.2.2 Femoropopliteal
2.2.3 Other
2.2.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
2.2.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
2.2.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloon for Peripheral Artery Disease Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Use Scenario
2.3.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Use Scenario (2021-2026)
2.4 Drug Eluting Balloon for Peripheral Artery Disease Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug Eluting Balloon for Peripheral Artery Disease Segment by Application
2.5.1 Hospitals
2.5.2 Ambulatory Surgery Centers
2.5.3 Catheterization Laboratories
2.5.4 Others
2.5.5 Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
2.5.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2021-2026)
2.5.5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Breakdown Data by Company
3.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Product Location Distribution
3.4.2 Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.4 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.6 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country
5.1.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region
6.1.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloon for Peripheral Artery Disease by Country
7.1.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease by Country
8.1.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.3 Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.4 Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors
11.3 Drug Eluting Balloon for Peripheral Artery Disease Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Acotec
13.4.1 Acotec Company Information
13.4.2 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Acotec Main Business Overview
13.4.5 Acotec Latest Developments
13.5 Philips
13.5.1 Philips Company Information
13.5.2 Philips Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Main Business Overview
13.5.5 Philips Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 MicroPort Medical
13.8.1 MicroPort Medical Company Information
13.8.2 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MicroPort Medical Main Business Overview
13.8.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Drug Eluting Balloon for Peripheral Artery Disease by Country/Region, 2021, 2025 & 2032
2.2 Drug Eluting Balloon for Peripheral Artery Disease Segment by Type
2.2.1 Iliac Artery
2.2.2 Femoropopliteal
2.2.3 Other
2.2.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Type
2.2.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
2.2.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2021-2026)
2.3 Drug Eluting Balloon for Peripheral Artery Disease Segment by Use Scenario
2.3.1 In-Stent Restenosi
2.3.2 De Novo
2.3.3 Small Vessel
2.3.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Use Scenario
2.3.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario (2021-2026)
2.3.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Use Scenario (2021-2026)
2.3.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Use Scenario (2021-2026)
2.4 Drug Eluting Balloon for Peripheral Artery Disease Segment by Balloon Platform Mechanics
2.4.1 Semi-/Compliant
2.4.2 Non-compliant
2.4.3 Other
2.4.4 Drug Eluting Balloon for Peripheral Artery Disease Sales by Balloon Platform Mechanics
2.4.4.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Balloon Platform Mechanics (2021-2026)
2.4.4.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Balloon Platform Mechanics (2021-2026)
2.5 Drug Eluting Balloon for Peripheral Artery Disease Segment by Application
2.5.1 Hospitals
2.5.2 Ambulatory Surgery Centers
2.5.3 Catheterization Laboratories
2.5.4 Others
2.5.5 Drug Eluting Balloon for Peripheral Artery Disease Sales by Application
2.5.5.1 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2021-2026)
2.5.5.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue and Market Share by Application (2021-2026)
2.5.5.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Drug Eluting Balloon for Peripheral Artery Disease Breakdown Data by Company
3.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Company (2021-2026)
3.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2021-2026)
3.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Company (2021-2026)
3.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2021-2026)
3.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2021-2026)
3.3 Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company
3.4 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Product Location Distribution
3.4.2 Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION
4.1 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Geographic Region (2021-2026)
4.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Drug Eluting Balloon for Peripheral Artery Disease Market Size by Country/Region (2021-2026)
4.2.1 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Sales by Country/Region (2021-2026)
4.2.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue by Country/Region (2021-2026)
4.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.4 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.5 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
4.6 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Growth
5 AMERICAS
5.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country
5.1.1 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
5.1.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
5.2 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
5.3 Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region
6.1.1 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2021-2026)
6.1.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2021-2026)
6.2 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
6.3 APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Drug Eluting Balloon for Peripheral Artery Disease by Country
7.1.1 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
7.1.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
7.2 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
7.3 Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease by Country
8.1.1 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026)
8.1.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026)
8.2 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026)
8.3 Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.3 Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
10.4 Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Drug Eluting Balloon for Peripheral Artery Disease Distributors
11.3 Drug Eluting Balloon for Peripheral Artery Disease Customer
12 WORLD FORECAST REVIEW FOR DRUG ELUTING BALLOON FOR PERIPHERAL ARTERY DISEASE BY GEOGRAPHIC REGION
12.1 Global Drug Eluting Balloon for Peripheral Artery Disease Market Size Forecast by Region
12.1.1 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Region (2027-2032)
12.1.2 Global Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Type (2027-2032)
12.7 Global Drug Eluting Balloon for Peripheral Artery Disease Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Medtronic
13.1.1 Medtronic Company Information
13.1.2 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.1.3 Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Medtronic Main Business Overview
13.1.5 Medtronic Latest Developments
13.2 Boston Scientific
13.2.1 Boston Scientific Company Information
13.2.2 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.2.3 Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Boston Scientific Main Business Overview
13.2.5 Boston Scientific Latest Developments
13.3 BD
13.3.1 BD Company Information
13.3.2 BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.3.3 BD Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 BD Main Business Overview
13.3.5 BD Latest Developments
13.4 Acotec
13.4.1 Acotec Company Information
13.4.2 Acotec Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.4.3 Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Acotec Main Business Overview
13.4.5 Acotec Latest Developments
13.5 Philips
13.5.1 Philips Company Information
13.5.2 Philips Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.5.3 Philips Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Philips Main Business Overview
13.5.5 Philips Latest Developments
13.6 Lepu Medical
13.6.1 Lepu Medical Company Information
13.6.2 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.6.3 Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Lepu Medical Main Business Overview
13.6.5 Lepu Medical Latest Developments
13.7 Eurocor
13.7.1 Eurocor Company Information
13.7.2 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.7.3 Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Eurocor Main Business Overview
13.7.5 Eurocor Latest Developments
13.8 MicroPort Medical
13.8.1 MicroPort Medical Company Information
13.8.2 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
13.8.3 MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 MicroPort Medical Main Business Overview
13.8.5 MicroPort Medical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Iliac Artery
Table 4. Major Players of Femoropopliteal
Table 5. Major Players of Other
Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Table 8. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2021-2026) & ($ million)
Table 9. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021-2026)
Table 10. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2021-2026) & (USD/Unit)
Table 11. Major Players of In-Stent Restenosi
Table 12. Major Players of De Novo
Table 13. Major Players of Small Vessel
Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Use Scenario (2021-2026) & (K Units)
Table 15. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario (2021-2026)
Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Use Scenario (2021-2026) & ($ million)
Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Use Scenario (2021-2026)
Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Use Scenario (2021-2026) & (USD/Unit)
Table 19. Major Players of Semi-/Compliant
Table 20. Major Players of Non-compliant
Table 21. Major Players of Other
Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 23. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 24. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 25. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 26. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Balloon Platform Mechanics (2021-2026) & (USD/Unit)
Table 27. Global Drug Eluting Balloon for Peripheral Artery Disease Sale by Application (2021-2026) & (K Units)
Table 28. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2021-2026)
Table 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2021-2026) & ($ million)
Table 30. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2021-2026)
Table 31. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2021-2026) & (USD/Unit)
Table 32. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Company (2021-2026) & (K Units)
Table 33. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2021-2026)
Table 34. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2021-2026)
Table 36. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company (2021-2026) & (USD/Unit)
Table 37. Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution and Sales Area
Table 38. Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
Table 39. Drug Eluting Balloon for Peripheral Artery Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Geographic Region (2021-2026)
Table 44. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2021-2026)
Table 48. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 51. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021-2026)
Table 52. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 54. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 55. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2021-2026) & (K Units)
Table 56. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2021-2026)
Table 57. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 59. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 60. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 61. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 63. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Drug Eluting Balloon for Peripheral Artery Disease
Table 69. Key Market Challenges & Risks of Drug Eluting Balloon for Peripheral Artery Disease
Table 70. Key Industry Trends of Drug Eluting Balloon for Peripheral Artery Disease
Table 71. Drug Eluting Balloon for Peripheral Artery Disease Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
Table 74. Drug Eluting Balloon for Peripheral Artery Disease Customer List
Table 75. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Medtronic Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 91. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 96. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. BD Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 100. BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 101. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. BD Main Business
Table 103. BD Latest Developments
Table 104. Acotec Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 105. Acotec Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 106. Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. Acotec Main Business
Table 108. Acotec Latest Developments
Table 109. Philips Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 110. Philips Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 111. Philips Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Philips Main Business
Table 113. Philips Latest Developments
Table 114. Lepu Medical Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 115. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 116. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Lepu Medical Main Business
Table 118. Lepu Medical Latest Developments
Table 119. Eurocor Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 120. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 121. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. Eurocor Main Business
Table 123. Eurocor Latest Developments
Table 124. MicroPort Medical Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 125. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 126. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. MicroPort Medical Main Business
Table 128. MicroPort Medical Latest Developments
Table 1. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Drug Eluting Balloon for Peripheral Artery Disease Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Iliac Artery
Table 4. Major Players of Femoropopliteal
Table 5. Major Players of Other
Table 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 7. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Table 8. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Type (2021-2026) & ($ million)
Table 9. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021-2026)
Table 10. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Type (2021-2026) & (USD/Unit)
Table 11. Major Players of In-Stent Restenosi
Table 12. Major Players of De Novo
Table 13. Major Players of Small Vessel
Table 14. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Use Scenario (2021-2026) & (K Units)
Table 15. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario (2021-2026)
Table 16. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Use Scenario (2021-2026) & ($ million)
Table 17. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Use Scenario (2021-2026)
Table 18. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Use Scenario (2021-2026) & (USD/Unit)
Table 19. Major Players of Semi-/Compliant
Table 20. Major Players of Non-compliant
Table 21. Major Players of Other
Table 22. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Balloon Platform Mechanics (2021-2026) & (K Units)
Table 23. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics (2021-2026)
Table 24. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Balloon Platform Mechanics (2021-2026) & ($ million)
Table 25. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Table 26. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Balloon Platform Mechanics (2021-2026) & (USD/Unit)
Table 27. Global Drug Eluting Balloon for Peripheral Artery Disease Sale by Application (2021-2026) & (K Units)
Table 28. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2021-2026)
Table 29. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Application (2021-2026) & ($ million)
Table 30. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application (2021-2026)
Table 31. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Application (2021-2026) & (USD/Unit)
Table 32. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Company (2021-2026) & (K Units)
Table 33. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company (2021-2026)
Table 34. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company (2021-2026) & ($ millions)
Table 35. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company (2021-2026)
Table 36. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Price by Company (2021-2026) & (USD/Unit)
Table 37. Key Manufacturers Drug Eluting Balloon for Peripheral Artery Disease Producing Area Distribution and Sales Area
Table 38. Players Drug Eluting Balloon for Peripheral Artery Disease Products Offered
Table 39. Drug Eluting Balloon for Peripheral Artery Disease Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 40. New Products and Potential Entrants
Table 41. Market M&A Activity & Strategy
Table 42. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Geographic Region (2021-2026) & (K Units)
Table 43. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Geographic Region (2021-2026)
Table 44. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Geographic Region (2021-2026) & ($ millions)
Table 45. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region (2021-2026)
Table 46. Global Drug Eluting Balloon for Peripheral Artery Disease Sales by Country/Region (2021-2026) & (K Units)
Table 47. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2021-2026)
Table 48. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country/Region (2021-2026) & ($ millions)
Table 49. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country/Region (2021-2026)
Table 50. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 51. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021-2026)
Table 52. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026) & ($ millions)
Table 53. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 54. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 55. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Region (2021-2026) & (K Units)
Table 56. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region (2021-2026)
Table 57. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue by Region (2021-2026) & ($ millions)
Table 58. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 59. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 60. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 61. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue by Country (2021-2026) & ($ millions)
Table 62. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 63. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 64. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Country (2021-2026) & (K Units)
Table 65. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Table 66. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Type (2021-2026) & (K Units)
Table 67. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales by Application (2021-2026) & (K Units)
Table 68. Key Market Drivers & Growth Opportunities of Drug Eluting Balloon for Peripheral Artery Disease
Table 69. Key Market Challenges & Risks of Drug Eluting Balloon for Peripheral Artery Disease
Table 70. Key Industry Trends of Drug Eluting Balloon for Peripheral Artery Disease
Table 71. Drug Eluting Balloon for Peripheral Artery Disease Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Drug Eluting Balloon for Peripheral Artery Disease Distributors List
Table 74. Drug Eluting Balloon for Peripheral Artery Disease Customer List
Table 75. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 76. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Region (2027-2032) & ($ millions)
Table 77. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 78. Americas Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 79. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Region (2027-2032) & (K Units)
Table 80. APAC Drug Eluting Balloon for Peripheral Artery Disease Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 81. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 82. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 83. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Country (2027-2032) & (K Units)
Table 84. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Country (2027-2032) & ($ millions)
Table 85. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Type (2027-2032) & (K Units)
Table 86. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Type (2027-2032) & ($ millions)
Table 87. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Forecast by Application (2027-2032) & (K Units)
Table 88. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Forecast by Application (2027-2032) & ($ millions)
Table 89. Medtronic Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 90. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 91. Medtronic Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 92. Medtronic Main Business
Table 93. Medtronic Latest Developments
Table 94. Boston Scientific Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 95. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 96. Boston Scientific Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 97. Boston Scientific Main Business
Table 98. Boston Scientific Latest Developments
Table 99. BD Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 100. BD Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 101. BD Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 102. BD Main Business
Table 103. BD Latest Developments
Table 104. Acotec Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 105. Acotec Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 106. Acotec Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 107. Acotec Main Business
Table 108. Acotec Latest Developments
Table 109. Philips Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 110. Philips Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 111. Philips Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 112. Philips Main Business
Table 113. Philips Latest Developments
Table 114. Lepu Medical Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 115. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 116. Lepu Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 117. Lepu Medical Main Business
Table 118. Lepu Medical Latest Developments
Table 119. Eurocor Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 120. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 121. Eurocor Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 122. Eurocor Main Business
Table 123. Eurocor Latest Developments
Table 124. MicroPort Medical Basic Information, Drug Eluting Balloon for Peripheral Artery Disease Manufacturing Base, Sales Area and Its Competitors
Table 125. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Product Portfolios and Specifications
Table 126. MicroPort Medical Drug Eluting Balloon for Peripheral Artery Disease Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 127. MicroPort Medical Main Business
Table 128. MicroPort Medical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Drug Eluting Balloon for Peripheral Artery Disease
Figure 2. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloon for Peripheral Artery Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Iliac Artery
Figure 12. Product Picture of Femoropopliteal
Figure 13. Product Picture of Other
Figure 14. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2026
Figure 15. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of In-Stent Restenosi
Figure 17. Product Picture of De Novo
Figure 18. Product Picture of Small Vessel
Figure 19. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario in 2026
Figure 20. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Use Scenario (2021-2026)
Figure 21. Product Picture of Semi-/Compliant
Figure 22. Product Picture of Non-compliant
Figure 23. Product Picture of Other
Figure 24. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics in 2026
Figure 25. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 26. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Hospitals
Figure 27. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Hospitals (2021-2026) & (K Units)
Figure 28. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Ambulatory Surgery Centers
Figure 29. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Ambulatory Surgery Centers (2021-2026) & (K Units)
Figure 30. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Catheterization Laboratories
Figure 31. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Catheterization Laboratories (2021-2026) & (K Units)
Figure 32. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Others
Figure 33. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Others (2021-2026) & (K Units)
Figure 34. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2025)
Figure 35. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application in 2026
Figure 36. Drug Eluting Balloon for Peripheral Artery Disease Sales by Company in 2026 (K Units)
Figure 37. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2026
Figure 38. Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company in 2026 ($ millions)
Figure 39. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company in 2026
Figure 40. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region in 2026
Figure 42. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 43. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 44. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 45. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 46. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 47. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 50. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2026
Figure 51. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Figure 52. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 53. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 54. United States Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region in 2026
Figure 59. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2021-2026)
Figure 60. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 61. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 62. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 66. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2026
Figure 70. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Figure 71. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 72. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 73. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 74. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 81. Egypt Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease in 2026
Figure 87. Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
Figure 88. Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease
Figure 89. Channels of Distribution
Figure 90. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Forecast by Region (2027-2032)
Figure 91. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Drug Eluting Balloon for Peripheral Artery Disease
Figure 2. Drug Eluting Balloon for Peripheral Artery Disease Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Drug Eluting Balloon for Peripheral Artery Disease Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2025)
Figure 10. Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Iliac Artery
Figure 12. Product Picture of Femoropopliteal
Figure 13. Product Picture of Other
Figure 14. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type in 2026
Figure 15. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Type (2021-2026)
Figure 16. Product Picture of In-Stent Restenosi
Figure 17. Product Picture of De Novo
Figure 18. Product Picture of Small Vessel
Figure 19. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Use Scenario in 2026
Figure 20. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Use Scenario (2021-2026)
Figure 21. Product Picture of Semi-/Compliant
Figure 22. Product Picture of Non-compliant
Figure 23. Product Picture of Other
Figure 24. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Balloon Platform Mechanics in 2026
Figure 25. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Balloon Platform Mechanics (2021-2026)
Figure 26. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Hospitals
Figure 27. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Hospitals (2021-2026) & (K Units)
Figure 28. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Ambulatory Surgery Centers
Figure 29. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Ambulatory Surgery Centers (2021-2026) & (K Units)
Figure 30. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Catheterization Laboratories
Figure 31. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Catheterization Laboratories (2021-2026) & (K Units)
Figure 32. Drug Eluting Balloon for Peripheral Artery Disease Consumed in Others
Figure 33. Global Drug Eluting Balloon for Peripheral Artery Disease Market: Others (2021-2026) & (K Units)
Figure 34. Global Drug Eluting Balloon for Peripheral Artery Disease Sale Market Share by Application (2025)
Figure 35. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Application in 2026
Figure 36. Drug Eluting Balloon for Peripheral Artery Disease Sales by Company in 2026 (K Units)
Figure 37. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Company in 2026
Figure 38. Drug Eluting Balloon for Peripheral Artery Disease Revenue by Company in 2026 ($ millions)
Figure 39. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Company in 2026
Figure 40. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Geographic Region (2021-2026)
Figure 41. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Geographic Region in 2026
Figure 42. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 43. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 44. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 45. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 46. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 47. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 48. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales 2021-2026 (K Units)
Figure 49. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue 2021-2026 ($ millions)
Figure 50. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2026
Figure 51. Americas Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Figure 52. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 53. Americas Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 54. United States Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 55. Canada Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 56. Mexico Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 57. Brazil Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 58. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Region in 2026
Figure 59. APAC Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Region (2021-2026)
Figure 60. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 61. APAC Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 62. China Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 63. Japan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 64. South Korea Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 65. Southeast Asia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 66. India Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 67. Australia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 68. China Taiwan Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 69. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country in 2026
Figure 70. Europe Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share by Country (2021-2026)
Figure 71. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 72. Europe Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 73. Germany Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 74. France Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 75. UK Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 76. Italy Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 77. Russia Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 78. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Country (2021-2026)
Figure 79. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Type (2021-2026)
Figure 80. Middle East & Africa Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share by Application (2021-2026)
Figure 81. Egypt Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 82. South Africa Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 83. Israel Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 84. Turkey Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 85. GCC Countries Drug Eluting Balloon for Peripheral Artery Disease Revenue Growth 2021-2026 ($ millions)
Figure 86. Manufacturing Cost Structure Analysis of Drug Eluting Balloon for Peripheral Artery Disease in 2026
Figure 87. Manufacturing Process Analysis of Drug Eluting Balloon for Peripheral Artery Disease
Figure 88. Industry Chain Structure of Drug Eluting Balloon for Peripheral Artery Disease
Figure 89. Channels of Distribution
Figure 90. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Forecast by Region (2027-2032)
Figure 91. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Region (2027-2032)
Figure 92. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Type (2027-2032)
Figure 93. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Type (2027-2032)
Figure 94. Global Drug Eluting Balloon for Peripheral Artery Disease Sales Market Share Forecast by Application (2027-2032)
Figure 95. Global Drug Eluting Balloon for Peripheral Artery Disease Revenue Market Share Forecast by Application (2027-2032)
